Ariad Pharmaceuticals downgraded

JPMorgan downgraded Ariad Pharmaceuticals Inc. (Nasdaq: ARIA) from a Neutral rating to an Underweight rating sending the stock price tumbling $1.01 to close at $9.37.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.